News
CSMG Technologies Announces Opening of Live Tissue Connect Headquarters in Central California
Corpus Christi, TX, February 26, 2008 -- CSMG Technologies, Inc., (OTCBB: CTUM - News), a technology management company, announced that its subsidiary, Live Tissue Connect ("LTC"), has opened its headquarters in Santa Barbara, California.
Don Robbins, President and CEO of CSMG Technologies, said, "We are pleased to have opened the LTC worldwide headquarters in Santa Barbara, California. We have expanded our patent portfolio, received CE Mark approval on our electrosurgery generator, and with commercial manufacturing of instruments and generators in-process, we need to have a facility for our growing staff."
"We believe that in Central California, where we're already performing most of our development, manufacturing and marketing work, would be ideal. Locating our office central to our suppliers and employees simply made the most economic sense. Also having a facility where we can host clinical and medical advisors, and in close proximity to our key research universities and teaching hospitals, is ideal," added Frank D'Amelio, President of LTC.
About Live Tissue Connect
LTC's surgical tissue bonding/welding device is a patented platform technology that bonds and reconnects human soft tissue through fusion, in contrast with conventional wound closing devices such as sutures, staples, sealant, or glues. LTC holds approximately 31 patents and pending patents in the U.S., Australia, Canada, European Union, Ukraine, and other countries.
For further information on CSMG Technologies and its various subsidiaries, please visit our website at www.csmgtechinternational.com.
Sign up to receive CSMG Technologies automated email press releases and other notifications: Please go to: www.csmgtechinternational.com/contact_information.html and fill-in information.
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934 as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.